<code id='FDE2D7E3F7'></code><style id='FDE2D7E3F7'></style>
    • <acronym id='FDE2D7E3F7'></acronym>
      <center id='FDE2D7E3F7'><center id='FDE2D7E3F7'><tfoot id='FDE2D7E3F7'></tfoot></center><abbr id='FDE2D7E3F7'><dir id='FDE2D7E3F7'><tfoot id='FDE2D7E3F7'></tfoot><noframes id='FDE2D7E3F7'>

    • <optgroup id='FDE2D7E3F7'><strike id='FDE2D7E3F7'><sup id='FDE2D7E3F7'></sup></strike><code id='FDE2D7E3F7'></code></optgroup>
        1. <b id='FDE2D7E3F7'><label id='FDE2D7E3F7'><select id='FDE2D7E3F7'><dt id='FDE2D7E3F7'><span id='FDE2D7E3F7'></span></dt></select></label></b><u id='FDE2D7E3F7'></u>
          <i id='FDE2D7E3F7'><strike id='FDE2D7E3F7'><tt id='FDE2D7E3F7'><pre id='FDE2D7E3F7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:454
          Frank Pallone -- health policy coverage from STAT
          Rep. Frank Pallone (D-N.J.) J. Scott Applewhite/AP

          WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives.

          Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pallone (D-N.J.).

          advertisement

          Two other prominent Democrats on relevant committees didn’t sign on: Rep. Richard Neal (D-Mass.), who had voiced concerns about the bill’s lack of transparency provisions requiring disclosure of private equity ownership, and Rep. Bobby Scott (D-Va.).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          FDA approves Moderna’s RSV vaccine, its second licensed product
          FDA approves Moderna’s RSV vaccine, its second licensed product

          TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Biotech stock slump in 2023: awaiting the turnaround

          AdobeThiswassupposedtobetheyearofthebiotechcomeback,whenpromisingnewmedicinesandhigh-dollarbuyoutswo